Search results for "EFFECTOR"

showing 10 items of 217 documents

Research in practice: The impact of interferon-α therapy on immune tolerance

2014

Interferon-α (IFN-α) is the only drug approved for adjuvant therapy of malignant melanoma and is also used in the treatment of hematological and solid tumors. Along with its proven clinical efficacy, IFN-α produces several side effects, particularly with regard to autoimmune disorders. Curious about symptoms of autoimmunity during IFN-α therapy, we asked whether IFN-α directly impacts on immune tolerance. We found that IFN-α does alter the function of tolerogenic dendritic cells (DC) as well as of induced and naturally occurring T-regulatory cells (nTregs). IFN-α blocks the tolerogenic phenotype of DC by inducing maturation and thus preventing the induction of inducible Tregs by DC. It also…

MAPK/ERK pathwayEffectorbusiness.industryMelanomaPhosphodiesteraseDermatologymedicine.disease_causemedicine.diseasePhenotypeAutoimmunityImmune toleranceImmunologymedicineAdjuvant therapybusinessJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

The role of death effector domain (DED)-containing proteins in acute oxidative cell injury in hepatocytes

2012

Abstract Apoptosis is a mechanism that regulates hepatic tissue homeostasis and contributes to both acute and chronic injury in liver disease. The apoptotic signaling cascade involves activation of the death-inducing signaling complex (DISC) and subsequent recruitment of proteins containing death effector domains (DED), which regulate downstream effector molecules. Prominent among these are the Fas-associated death domain (FADD) and the cellular caspase 8-like inhibitory protein (cFLIP), and alterations in these proteins can lead to severe disruption of physiological processes, including acute liver failure or hepatocellular carcinoma. Their role in cell signaling events independent of the …

MAPK/ERK pathwayProgrammed cell deathDeath Domain Receptor Signaling Adaptor ProteinsbiologyBlotting WesternBiochemistryArticleCell biologyMiceMicroscopy FluorescencePhysiology (medical)Cell Line TumorDeath-inducing signaling complexModels Animalbiology.proteinHepatocytesAnimalsHumansDeath effector domainFADDSignal transductionCaspaseDeath domainSignal Transduction
researchProduct

Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion

2011

Article Open access plus; International audience; The use of TRAIL/APO2L and monoclonal antibodies targeting TRAIL receptors for cancer therapy holds great promise, due to their ability to restore cancer cell sensitivity to apoptosis in association with conventional chemotherapeutic drugs in a large variety of tumors. TRAIL-induced cell death is tightly regulated right from the membrane and at the DISC (Death-Inducing Signaling Complex) level. The following patent and literature review aims to present and highlight recent findings of the deadly discussion that determines tumor cell fate upon TRAIL engagement.

MESH: Cell DeathMESH: Signal TransductionCancer ResearchApoptosisTRAILMESH : Models BiologicalscaffoldCell membrane0302 clinical medicineDrug DiscoveryMESH: AnimalsPharmacology (medical)Receptordeath effector domain0303 health sciencesCell DeathGeneral MedicineTRAIL-R4.3. Good healthCell biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisSignal transductionMESH : Apoptosis Regulatory ProteinsSignal TransductionProgrammed cell deathc-FLIPdeath domainmedicine.drug_classMESH : Cell MembraneCancer therapyBiologyMonoclonal antibodyModels BiologicalArticle03 medical and health sciencesmedicineAnimalsHumansChemotherapy[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyMESH: Receptors TNF-Related Apoptosis-Inducing LigandMESH : Receptors TNF-Related Apoptosis-Inducing Ligand[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular Biology030304 developmental biologyMESH : Signal TransductionMESH: HumansMESH: Apoptosis Regulatory ProteinsMESH: ApoptosisMESH : HumansCell MembraneMESH: Models BiologicalDISCReceptors TNF-Related Apoptosis-Inducing LigandApoptosisMESH : Cell DeathFADDCancer cellMESH : AnimalsApoptosis Regulatory ProteinsMESH : ApoptosisMESH: Cell MembraneRecent Patents on Anti-Cancer Drug Discovery
researchProduct

Evolutionary Dissection of the Dot/Icm System Based on Comparative Genomics of 58 Legionella Species

2019

14 páginas, 2 figuras, 2 tablas

MESH: Selection GeneticLegionella pneumophilaMESH: Bacterial Proteins/metabolism*Negative selectionPositive-selectionDot/Icm systemMESH: PhylogenyNegative-selectionPhylogenyMESH: Evolution MolecularRecombination Genetic0303 health sciencesEffectorMESH: GenomicsGenomics3. Good healthCell biologypositive-selectionDiversifying-selectionMESH: Recombination GeneticMESH: Membrane ProteinsResearch ArticleSignal peptidenegative-selectionEvolutionLegionellaMESH: Carrier ProteinsBiologyMESH: Bacterial Proteins/geneticsEvolution MolecularType IV Secretion Systems03 medical and health sciencesdiversifying-selectionMESH: Type IV Secretion Systems*Bacterial Proteins[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]evolutionGeneticsSecretionSelection GeneticEcology Evolution Behavior and SystematicsMESH: Legionella/classification030304 developmental biologyComparative genomicsMESH: Legionella/metabolism030306 microbiologyMESH: Legionella/geneticsMembrane ProteinsPeriplasmic spacebiology.organism_classificationCytoplasmCarrier Proteins
researchProduct

4-Dechloro-14-deoxy-oxacyclododecindione and 14-deoxy-oxacylododecindione, two inhibitors of inducible connective tissue growth factor expression fro…

2015

Connective tissue growth factor (CTGF/CCN2), a member of the CCN superfamily of secreted cysteine-rich glycoproteins, is a central mediator of tissue remodeling and fibrosis. CTGF is suggested to be an important down-stream effector of transforming growth factor-beta (TGF-β) signaling and has therefore reached considerable pathophysiological relevance because of its involvement in the pathogenesis of fibrotic diseases, atherosclerosis, skin scarring, and other conditions with excess production of connective tissue. In a search for inhibitors of inducible CTGF expression from fungi, two new macrocyclic lactones, namely 4-dechloro-14-deoxy-oxacyclododecindione (1) and 14-deoxy-oxacylododecind…

Macrocyclic Compoundsmedicine.medical_treatmentClinical BiochemistryPharmaceutical ScienceConnective tissueBiochemistryAscomycotaFibrosisDrug DiscoverymedicineHumansMolecular BiologyTube formationintegumentary systemEffectorChemistryGrowth factorOrganic ChemistryConnective Tissue Growth FactorHep G2 CellsTransfectionmedicine.diseaseMolecular biologyCTGFmedicine.anatomical_structureBiochemistryMolecular MedicineTransforming growth factorBioorganic & Medicinal Chemistry
researchProduct

Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth

2018

Abstract The Wnt/β-catenin pathway regulates T-cell functions, including the repression of effector functions to the advantage of memory development via Tcf1. In a companion study, we demonstrate that, in human cancers, Wnt3a/β-catenin signaling maintains tumor-infiltrating T cells in a partially exhausted status. Here, we have investigated the effects of Wnt3a neutralization in vivo in a mouse tumor model. Abundant Wnt3a was released, mostly by stromal cells, in the tumor microenvironment. We tested whether Wnt3a neutralization in vivo could rescue the effector capacity of tumor-infiltrating T cells, by administering an antibody to Wnt3a to tumor-bearing mice. This therapy restrained tumor…

Male0301 basic medicineCancer Researchanimal structuresStromal cellT cellmedicine.medical_treatmentImmunologyAdenocarcinomaCD8-Positive T-LymphocytesDendritic CellSettore MED/0403 medical and health sciencesLymphocytes Tumor-Infiltrating0302 clinical medicineImmunology; Cancer Research; Wnt; Beta-catenin.Cell Line TumorWnt3A ProteinmedicineAnimalsHumansWnt Signaling PathwayColonic NeoplasmTumor microenvironmentAnimalChemistryEffectorStromal CellWnt signaling pathwayCD8-Positive T-LymphocyteDendritic CellsImmunotherapyDendritic cellCell biologyMice Inbred C57BLbody regions030104 developmental biologymedicine.anatomical_structureLymphocyte Transfusion030220 oncology & carcinogenesisColonic Neoplasmsembryonic structuresImmunotherapyStromal CellsCD8HumanCancer Immunology Research
researchProduct

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

2016

Lymphoid organs, in which antigen presenting cells (APCs) are in close proximity to T cells, are the ideal microenvironment for efficient priming and amplification of T-cell responses. However, the systemic delivery of vaccine antigens into dendritic cells (DCs) is hampered by various technical challenges. Here we show that DCs can be targeted precisely and effectively in vivo using intravenously administered RNA-lipoplexes (RNA-LPX) based on well-known lipid carriers by optimally adjusting net charge, without the need for functionalization of particles with molecular ligands. The LPX protects RNA from extracellular ribonucleases and mediates its efficient uptake and expression of the encod…

Male0301 basic medicineLymphoid TissueT-Lymphocytesmedicine.medical_treatmentStatic ElectricityPriming (immunology)BiologyLymphocyte ActivationAutoantigensCancer VaccinesMice03 medical and health sciences0302 clinical medicineAntigenCancer immunotherapyAntigens NeoplasmInterferonmedicineAnimalsHumansAntigen-presenting cellAntigens ViralMelanomaAntigen PresentationDrug CarriersMembrane GlycoproteinsMultidisciplinaryInnate immune systemClinical Trials Phase I as TopicEffectorMacrophagesRNADendritic CellsMice Inbred C57BLDisease Models Animal030104 developmental biologyToll-Like Receptor 7030220 oncology & carcinogenesisInterferon Type IImmunologyCancer researchNanoparticlesRNAAdministration IntravenousFemaleImmunotherapymedicine.drugNature
researchProduct

Diminished Contact Hypersensitivity Response in IL‐4 Deficient Mice at a Late Phase of the Elicitation Reaction

1997

Contact hypersensitivity (CHS) is thought to depend on the activation of T cells of Th1 and/or Tc1 type. The role of Th2/Tc2 cells in the contact allergic reaction is not clear. The aim of this study was to analyse the functional contribution of Th2/Tc2 cells in CHS using the interleukin-4 (IL-4) deficient mouse model. Interleukin-4 deficient (IL4T) and control (wt) mice were sensitized by epicutaneous application of 2,4-dinitrofluorobenzene. The ear swelling response measured 24 h after challenge was similar in IL4T and control mice. However, from 48 h onwards, ear swelling values were significantly reduced in IL4T mice. The stimulatory capacity of freshly isolated as well as 3-day culture…

MaleImmunologyPopulationCellCell CountBiologyDermatitis ContactLymphocyte ActivationFlow cytometryMiceT-Lymphocyte SubsetsmedicineAnimalseducationInterleukin 4SkinMice Inbred BALB Ceducation.field_of_studymedicine.diagnostic_testEpidermis (botany)EffectorT-cell receptorContact hypersensitivityReceptors Antigen T-Cell gamma-deltaDendritic CellsGeneral MedicineFlow CytometryMolecular biologyMice Mutant StrainsMice Inbred C57BLmedicine.anatomical_structureLangerhans CellsImmunologyFemaleInterleukin-4EpidermisScandinavian Journal of Immunology
researchProduct

Nucleoside phosphotransferase in animal tissues. Tissue distribution and kinetic properties

1985

Amphibian, avian and mammal tissues contain a nucleoside phosphotransferase clearly different from those previously described in vegetables and bacteria. Whatever the animal source, the enzyme showed many similar characteristics as far as substrate specificity, dependence upon Mg2+, instability at 37 degrees C, and the protecting effect of nucleotides were concerned. Moreover, when submitted to gel filtration, the enzyme behaved in all cases as a dissociable high molecular weight protein, whose degree of association was controlled by nucleotides. In amphibian and avian tissues multiple forms of the enzyme seem to be present which differ for the substrate concentration at half-maximal veloci…

MaleRanidaeClinical BiochemistryKineticsSize-exclusion chromatographyChick EmbryoBiologySubstrate SpecificityCricetinaeSettore BIO/10 - BiochimicaNucleoside phosphotransferaseIntestine SmallTestisAnimalsNucleotideMagnesiumHorsesMolecular Biologychemistry.chemical_classificationEffectorPhosphotransferasesTemperatureBrainCell BiologyGeneral Medicinebiology.organism_classificationRatsKineticsEnzymeNucleoside phosphotransferaseTissue distributionchemistryBiochemistryChromatography GelCattleRabbitsChickensPhosphotransferasesBacteriaSpleen
researchProduct

Analysis of memory and effector CD8+ T cell subsets in chronic graft-versus-host disease.

2009

In humans, the selective depletion of CD8+ cells may prevent GVHD after allogeneic transplantation. These cells can infiltrate and damage target tissues. It is of interest to investigate the phenotypical characteristics and cytotoxic properties of the different CD8+ subsets in cGVHD patients. In a preliminary study we found that patients with cGVHD had a markedly elevated percentage of peripheral blood CCR7−/CD45RA+ cells compared to patients without cGVHD; conversely, the CCR7+/CD45RA+ subsets of CD8+ cells was significantly decreased. In this study, we report in depth on the phenotype of effector T cell subsets in cGVHD patients, as well as their proliferative capability, cytotoxic prope…

MaleReceptors CCR7T cellImmunologyGraft vs Host DiseaseC-C chemokine receptor type 7CD8-Positive T-LymphocytesLymphocyte ActivationGranzymesimmune system diseasesmedicineImmunology and AllergyCytotoxic T cellHumansAgedPharmacologybiologyEffectorChemistryPerforinMiddle Agedmedicine.diseaseGraft-versus-host diseasemedicine.anatomical_structureGranzymePerforinImmunologyChronic Diseasebiology.proteinLeukocyte Common AntigensFemaleImmunologic MemoryCD8International journal of immunopathology and pharmacology
researchProduct